Final NHS green light for Allergan’s IBS-D drug

31st August 2017 Uncategorised 0

Allergan’s Truberzi has become the first treatment for irritable bowel syndrome with diarrhoea (IBS-D) to be reviewed and recommended by the National Institute for Health and Care Excellence for use on the NHS in England and Wales.

More: Final NHS green light for Allergan’s IBS-D drug
Source: News